在国际上，筛查计划和临床实践指南建议老年人何时应使用年龄上限停止癌症筛查，但尚不清楚老年人如何看待这些建议。旨在检查老年人对于超出建议上限继续或停止癌症筛查的看法和经验乳腺癌、宫颈癌、前列腺癌和肠癌的年龄限制。定性、半结构化访谈。澳大利亚，电话。总共 29 名社区居住的老年人（≥70 岁）；从组织时事通讯、邮件列表和 Facebook 广告中招募。访谈经过录音、转录，并使用框架分析进行主题分析。首先，老年人处于信任建议和积极决定癌症筛查之间的区间，其中一些人不确定。其次，参与者报告说与健康专业人员就癌症筛查进行的深入讨论有限。在初级保健中，讨论的重点是检查他们是否了解最新的筛查或检查结果。讨论大多只有在老年人主动发起时才会发生。最后，参与者对筛查建议和潜在结果有了社会和自我构建的理解。人们认为设定年龄上限的原因是成本、降低癌症风险或年龄歧视。了解筛查风险与他们自己的社会经历有关（例如，分享关于癌症治疗不良结果的朋友的故事，或与朋友/家人讨论有关前列腺筛查的争议）。直接面向患者的信息和临床医生的支持可能有助于改善沟通关于随着年龄的增长癌症筛查的获益与危害比率的变化，并增加对癌症筛查计划年龄上限的基本原理的理解。© 作者 2023。由牛津大学出版社代表英国老年病学会出版。版权所有。如需权限，请发送电子邮件至：journals.permissions@oup.com。

Internationally, screening programmes and clinical practice guidelines recommend when older adults should stop cancer screening using upper age limits, but it is unknown how older adults view these recommendations.To examine older adults' views and experiences about continuing or stopping cancer screening beyond the recommended upper age limit for breast, cervical, prostate and bowel cancer.Qualitative, semi-structured interviews.Australia, telephone.A total of 29 community-dwelling older adults (≥70-years); recruited from organisation newsletters, mailing lists and Facebook advertisements.Interviews were audio-recorded, transcribed and analysed thematically using Framework Analysis.Firstly, older adults were on a spectrum between trusting recommendations and actively deciding about cancer screening, with some who were uncertain. Secondly, participants reported limited in-depth discussions with health professionals about cancer screening. In primary care, discussions were focused on checking they were up to date with screening or going over results. Discussions mostly only occurred if older adults initiated themselves. Finally, participants had a socially- and self-constructed understanding of screening recommendations and potential outcomes. Perceived reasons for upper age limits were cost, reduced cancer risk or ageism. Risks of screening were understood in relation to their own social experiences (e.g. shared stories about friends with adverse outcomes of cancer treatment or conversations with friends/family about controversy around prostate screening).Direct-to-patient information and clinician support may help improve communication about the changing benefit to harm ratio of cancer screening with increasing age and increase understanding about the rationale for an upper age limit for cancer screening programmes.© The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.